Low testosterone and high C-reactive protein concentrations predict low hematocrit in type 2 diabetes

Diabetes Care

Volumn 29, Issue 10, 2006, Pages 2289-2294

  Bhatia, Vishal ^a   Chaudhuri, Ajay ^a   Tomar, Rashmi ^a   Dhindsa, Sandeep ^a   Ghanim, Husam ^a   Dandona, Paresh ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b Diabetes Endocrinology Center of Western New York   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; TESTOSTERONE;

ADULT; AGED; ARTICLE; CALCULATION; CHRONIC INFLAMMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ERYTHROPOIESIS; HEMATOCRIT; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMOCHROMIC NORMOCYTIC ANEMIA; PREDICTION; PREVALENCE; PROTEIN BLOOD LEVEL; TERTIARY HEALTH CARE; TESTOSTERONE BLOOD LEVEL;

ADULT; AGED; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; HEMATOCRIT; HUMANS; HYPOGONADISM; MALE; MIDDLE AGED; TESTOSTERONE;

EID: 33845467935     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-0637     Document Type: Article

References (24)

1. Dhindsa S, Prabhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A, Dandona P: Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab 89:5462-5468, 2004
2. Tomar R, Dhindsa S, Chaudhuri A, Mohanty P, Garg R, Dandona P: Contrasting testosterone concentrations in type 1 and type 2 diabetes. Diabetes Care 29:1120-1122, 2006
3. Shahidi NT: Androgens and erythropoiesis. N Engl J Med 289:72-80, 1973
4. Means RT Jr, Krantz SB: Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 80:1639-1647, 1992
5. Means RT Jr, Krantz SB: Inhibition of human erythroid colony-forming units by tumor necrosis factor requires beta interferon. J Clin Invest 91:416-419, 1993
6. Means RT, Jr, Krantz SB, Luna J, Marsters SA, Ashkenazi A: Inhibition of murine erythroid colony formation in vitro by interferon gamma and correction by interferon receptor immunoadhesin. Blood 83:911-915, 1994
7. Voulgari PV, Kolios G, Papadopoulos GK, Katsaraki A, Seferiadis K, Drosos AA: Role of cytokines in the pathogenesis of anemia of chronic disease in rheumatoid arthritis. Clin Immunol 92:153-160, 1999
8. Vermeulen A, Verdonck L, Kaufman JM: A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666-3672, 1999
9. Morley JE, Patrick P, Perry HM 3rd: Evaluation of assays available to measure free testosterone. Metabolism 51:554-559, 2002
10. Vermeulen A, Kaufman JM: Diagnosis of hypogonadism in the aging male. Aging Male 5:170-176, 2002
11. Yeh ET: CRP as a mediator of disease. Circulation 109:II11-II14, 2004
12. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973-979, 1997
13. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 97:425-428, 1998
14. Woollard KJ, Phillips DC, Griffiths HR: Direct modulatory effect of C-reactive protein on primary human monocyte adhesion to human endothelial cells. Clin Exp Immunol 130:256-262, 2002
15. Nan B, Yang H, Yan S, Lin PH, Lumsden AB, Yao Q, Chen C: C-reactive protein decreases expression of thrombomodulin and endothelial protein C receptor in human endothelial cells. Surgery 138:212-222, 2005
16. Yang H, Nan B, Yan S, Li M, Yao Q, Chen C: C-reactive protein decreases expression of VEGF receptors and neuropilins and inhibits VEGF165-induced cell proliferation in human endothelial cells. Biochem Biophys Res Commun 333:1003-1010, 2005
17. Singh U, Devaraj S, Jialal I: C-reactive protein decreases tissue plasminogen activator activity in human aortic endothelial cells: evidence that C-reactive protein is a procoagulant. Arterioscler Thromb Vasc Biol 25:2216-2221, 2005
18. Bisoendial RJ, Kastelein JJ, Levels JH, Zwaginga JJ, van den Bogaard B, Reitsma PH, Meijers JC, Hartman D, Levi M, Stroes ES: Activation of inflammation and coagulation after infusion of C-reactive protein in humans. Circ Res 96:714-716, 2005
19. Papadaki HA, Kritikos HD, Gemetzi C, Koutala H, Marsh JC, Boumpas DT, Eliopoulos GD: Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor α-mediated effect. Blood 99:1610-1619, 2002
20. Papadaki HA, Kritikos HD, Valatas V, Boumpas DT, Eliopoulos GD: Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-α antibody therapy. Blood 100:474-482, 2002
21. Schilling RF: Anemia of chronic disease: a misnomer. Ann Intern Med 115:572-573, 1991
22. Salvi R, Castillo E, Voirol MJ, Glauser M, Rey JP, Gaillard RC, Vollenweider P, Pralong FP: GnRH-expressing neurons immortalized conditionally are activated by insulin: implication of the MAP kinase pathway. Endocrinology 147:816-826, 2006
23. Natali A, Toschi E, Baldeweg S, Casolaro A, Baldi S, Sironi AM, Yudkin JS, Ferrannini E: Haematocrit, type 2 diabetes, and endothelium-dependent vasodilatation of resistance vessels. Eur Heart J 26:464-471, 2005
24. Smith GD, Ben-Shlomo Y, Beswick A, Yarnell J, Lightman S, Elwood P: Cortisol, testosterone, and coronary heart disease: prospective evidence from the Caerphilly study. Circulation 112:332-340, 2005